Czechia – Pharmaceutical products – Medicinal product containing the active substance FARICIMAB
The subject matter of the public contract is the continuous supply of a medicinal product containing the active substance faricimab (ATC S01LA09) for the treatment of patients in the approved indications according to the SPC valid on the date of submission of tenders, to the extent required by the contracting authority. C
Opportunity description
The subject matter of the public contract is the continuous supply of a medicinal product containing the active substance faricimab (ATC S01LA09) for the treatment of patients in the approved indications according to the SPC valid on the date of submission of tenders, to the extent required by the contracting authority. The contracting authority's objective is to ensure the continuous supply of medicinal products for the treatment of patients for its activities for a period of 1 year from the entry into force of the framework purchase agreement. Procedure: open. Estimated value: 8,432,640 CZK. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.